Human adipose tissue-derived mesenchymal stem cells: Characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas

European Journal of Cancer

Volumn 48, Issue 1, 2012, Pages 129-137

  Choi, Seung Ah ^a   Lee, Ji Yeoun ^a   Wang, Kyu Chang ^a   Phi, Ji Hoon ^a   Song, Sang Hoon ^b   Song, Junghan ^b   Kim, Seung Ki ^a  

^a Seoul National University Children's Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Adipose tissue derived mesenchymal stem cells; Brainstem glioma; Carboxylesterase; Prodrug gene therapy

Indexed keywords

5' NUCLEOTIDASE; 7 ETHYL 10 HYDROXYCAMPTOTHECIN; CARBOXYLESTERASE; DRUG VEHICLE; IRINOTECAN; PRODRUG; THY 1 ANTIGEN;

ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL MIGRATION; CONTROLLED STUDY; DNA MODIFICATION; FIBROBLAST; GENE DIRECTED ENZYME PRODRUG THERAPY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NONHUMAN; PONTINE GLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TREATMENT OUTCOME;

ADIPOSE TISSUE; ANIMALS; BRAIN STEM NEOPLASMS; CARBOXYLESTERASE; CELL DIFFERENTIATION; CELLS, CULTURED; DRUG CARRIERS; ENZYME REPLACEMENT THERAPY; FEMALE; GENE THERAPY; GLIOMA; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; PRODRUGS; RABBITS; RATS; RATS, INBRED F344;

EID: 80053536433     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.04.033     Document Type: Article

References (34)

1. H. Okada, K.L. Low, and G. Kohanbash Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas J Neurooncol 88 2008 245 250
2. M.T. Jennings, M.L. Freeman, and M.J. Murray Strategies in the treatment of diffuse pontine gliomas: the therapeutic role of hyperfractionated radiotherapy and chemotherapy J Neurooncol 28 1996 207 222
3. K.S. Aboody, A. Brown, and N.G. Rainov Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas Proc Natl Acad Sci USA 97 2000 12846 12851
4. S. Benedetti, B. Pirola, and B. Pollo Gene therapy of experimental brain tumors using neural progenitor cells Nat Med 6 2000 447 450
5. S.K. Kim, T.G. Cargioli, and M. Machluf PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model Clin Cancer Res 11 2005 5965 5970
6. S.K. Kim, S.U. Kim, and I.H. Park Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression Clin Cancer Res 12 2006 5550 5556
7. L.G. Menon, K. Kelly, and H.W. Yang Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy Stem Cells 27 2009 2320 2330
8. A. Nakamizo, F. Marini, and T. Amano Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas Cancer Res 65 2005 3307 3318
9. D.H. Lee, Y. Ahn, and S.U. Kim Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells Clin Cancer Res 15 2009 4925 4934
10. S. Bobis, D. Jarocha, and M. Majka Mesenchymal stem cells: characteristics and clinical applications Folia Histochem Cytobiol 44 2006 215 230
11. H. Egusa, F.E. Schweizer, C.C. Wang, Y. Matsuka, and I. Nishimura Neuronal differentiation of bone marrow-derived stromal stem cells involves suppression of discordant phenotypes through gene silencing J Biol Chem 280 2005 23691 23697
12. T. Utsunomiya, M. Shimada, and S. Imura Human adipose-derived stem cells: potential clinical applications in surgery Surg Today 41 2011 18 23
13. L. Kucerova, V. Altanerova, M. Matuskova, S. Tyciakova, and C. Altaner Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy Cancer Res 67 2007 6304 6313
14. S.A. Choi, S.K. Hwang, and K.C. Wang Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma Neuro Oncol 13 2011 61 69
15. D.Y. Chang, S.W. Yoo, and Y. Hong The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase Int J Cancer 127 2010 1975 1983
16. M.K. Danks, K.J. Yoon, and R.A. Bush Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma Cancer Res 67 2007 22 25
17. M. Wierdl, C.L. Morton, and J.K. Weeks Sensitization of human tumor cells to CPT-11 via adenoviral-mediated delivery of a rabbit liver carboxylesterase Cancer Res 61 2001 5078 5082
18. G.I. Jallo, A. Volkov, C. Wong, B.S. Carson Sr., and M.B. Penno A novel brainstem tumor model: functional and histopathological characterization Childs Nerv Syst 22 2006 1519 1525
19. D. Baksh, L. Song, and R.S. Tuan Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy J Cell Mol Med 8 2004 301 316
20. D. Bexell, S. Scheding, and J. Bengzon Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors Mol Ther 18 2010 1067 1075
21. M. Dominici, K. Le Blanc, and I. Mueller Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 8 2006 315 317
22. E. Anghileri, S. Marconi, and A. Pignatelli Neuronal differentiation potential of human adipose-derived mesenchymal stem cells Stem Cells Dev 17 2008 909 916
23. K.M. Safford, K.C. Hicok, and S.D. Safford Neurogenic differentiation of murine and human adipose-derived stromal cells Biochem Biophys Res Commun 294 2002 371 379
24. B.M. Strem, K.C. Hicok, and M. Zhu Multipotential differentiation of adipose tissue-derived stem cells Keio J Med 54 2005 132 141
25. K.M. Safford, and H.E. Rice Stem cell therapy for neurologic disorders: therapeutic potential of adipose-derived stem cells Curr Drug Targets 6 2005 57 62
26. A.C. Heinrich, S.A. Patel, B.Y. Reddy, R. Milton, and P. Rameshwar Multi- and inter-disciplinary science in personalized delivery of stem cells for tissue repair Curr Stem Cell Res Ther 4 2009 16 22
27. K.J. Pulkkanen, and S. Yla-Herttuala Gene therapy for malignant glioma: current clinical status Mol Ther 12 2005 585 598
28. A.P. Byrnes, J.E. Rusby, M.J. Wood, and H.M. Charlton Adenovirus gene transfer causes inflammation in the brain Neuroscience 66 1995 1015 1024
29. A.J. Zermansky, F. Bolognani, and D. Stone Towards global and long-term neurological gene therapy: unexpected transgene dependent, high-level, and widespread distribution of HSV-1 thymidine kinase throughout the CNS Mol Ther 4 2001 490 498
30. C. Altaner Prodrug cancer gene therapy Cancer Lett 270 2008 191 201
31. K.S. Aboody, J. Najbauer, and M.K. Danks Stem and progenitor cell-mediated tumor selective gene therapy Gene Ther 15 2008 739 752
32. M.D. Prados, K. Lamborn, and W.K. Yung A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study Neuro Oncol 8 2006 189 193
33. J.J. Vredenburgh, A. Desjardins, and J.E. Herndon 2nd Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma Clin Cancer Res 13 2007 1253 1259
34. R. Torcuator, R. Zuniga, R. Loutfi, and T. Mikkelsen Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report J Neurooncol 93 2009 409 412